PT-141
Bremelanotide — Melanocortin Agonist
Cyclic heptapeptide analogue of alpha-MSH acting as a non-selective melanocortin receptor agonist (MC1R, MC3R, MC4R). Studied for central modulation of sexual arousal and function through hypothalamic pathways.
Format
10mg / vial
Purity
>99.1%
Category
Hormonal
Storage
2–8 °C
Research Price
€69
10mg / vial
RESEARCH USE ONLY
This compound is sold exclusively for in-vitro laboratory research. It is not intended for human consumption, therapeutic use, or self-administration. You must be 18+ and a qualified researcher to purchase.
Complete Your Research with the Pen Kit
Precise, painless, repeatable. The clinical-grade injection pen with 32G ultra-fine needles, bacteriostatic water, and your choice of peptide — ready to use out of the box.
€189
View details →Documented Research Parameters
Research Dose
0.5–2 mg
Frequency
As needed (single administration per research session)
Duration
Single dose studies; repeat as per research design
Half-Life
~3.9 hours
Route(s)
Subcutaneous · Intranasal
Solubility
Water
Reconstitution
2 ml bacteriostatic water per 10 mg vial
Key Research Findings
PT-141 acts centrally — unlike PDE5 inhibitors which act peripherally. Works via hypothalamic dopamine release.
Onset: 45–60 minutes post-administration in research models; duration ~6–12 hours.
Also studied for female arousal dysfunction — the published clinical trial data includes female subjects.
FDA-approved as bremelanotide (Vyleesi) for HSDD — providing clinical pharmacology context.
Administration Reference
Subcutaneous administration in the lower abdominal region. Onset of pharmacological effect is observed at 30–60 minutes in research models; duration 6–12 hours. Intranasal route explored but subcutaneous shows superior bioavailability data.
IMPORTANT RESEARCH DISCLAIMER
This compound is for in-vitro research and laboratory use only. It has not been evaluated or approved by any regulatory authority for human therapeutic use. It must not be used as a food, drug, or cosmetic. SYNTHEXA assumes no liability for misuse. Handle in accordance with Good Laboratory Practice.